160 related articles for article (PubMed ID: 29330472)
21. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma.
Nelson LT; Paxman RJ; Xu J; Webb B; Powers ET; Kelly JW
Amyloid; 2021 Mar; 28(1):24-29. PubMed ID: 32811187
[TBL] [Abstract][Full Text] [Related]
22. Transthyretin deposition in familial amyloidotic polyneuropathy.
Saraiva MJ; Magalhaes J; Ferreira N; Almeida MR
Curr Med Chem; 2012; 19(15):2304-11. PubMed ID: 22471982
[TBL] [Abstract][Full Text] [Related]
23. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4.
Du M; Martin A; Hays F; Johnson J; Farjo RA; Farjo KM
Mol Vis; 2017; 23():185-197. PubMed ID: 28400700
[TBL] [Abstract][Full Text] [Related]
24. Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.
Ohta M; Sugano A; Hatano N; Sato H; Shimada H; Niwa H; Sakaeda T; Tei H; Sakaki Y; Yamamura KI; Takaoka Y
Transgenic Res; 2018 Feb; 27(1):15-23. PubMed ID: 29288430
[TBL] [Abstract][Full Text] [Related]
25. Rescue of retinal morphology and function in a humanized mouse at the mouse retinol-binding protein locus.
Liu L; Suzuki T; Shen J; Wakana S; Araki K; Yamamura KI; Lei L; Li Z
Lab Invest; 2017 Apr; 97(4):395-408. PubMed ID: 28134916
[TBL] [Abstract][Full Text] [Related]
26. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
27. Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition.
Ferreira N; Santos SA; Domingues MR; Saraiva MJ; Almeida MR
Biochim Biophys Acta; 2013 Jan; 1832(1):39-45. PubMed ID: 23069388
[TBL] [Abstract][Full Text] [Related]
28. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus.
Frey SK; Spranger J; Henze A; Pfeiffer AF; Schweigert FJ; Raila J
Metabolism; 2009 Oct; 58(10):1386-92. PubMed ID: 19501859
[TBL] [Abstract][Full Text] [Related]
29. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
[TBL] [Abstract][Full Text] [Related]
30. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Tojo K; Sekijima Y; Kelly JW; Ikeda S
Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
[TBL] [Abstract][Full Text] [Related]
31. TTR exon-humanized mouse optimal for verifying new therapies for FAP.
Li Z; Kanazashi H; Tokashiki Y; Fujikawa R; Okagaki A; Katoh S; Kojima K; Haruna K; Matsushita N; Ishikawa TO; Chen H; Yamamura K
Biochem Biophys Res Commun; 2022 Apr; 599():69-74. PubMed ID: 35176627
[TBL] [Abstract][Full Text] [Related]
32. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Almeida MR; Macedo B; Cardoso I; Alves I; Valencia G; Arsequell G; Planas A; Saraiva MJ
Biochem J; 2004 Jul; 381(Pt 2):351-6. PubMed ID: 15080795
[TBL] [Abstract][Full Text] [Related]
33. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
[TBL] [Abstract][Full Text] [Related]
34. Recent progress in the understanding and treatment of transthyretin amyloidosis.
Sekijima Y
J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
[TBL] [Abstract][Full Text] [Related]
35. C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.
Panayiotou E; Fella E; Papacharalambous R; Malas S; Saraiva MJ; Kyriakides T
PLoS One; 2017; 12(4):e0175767. PubMed ID: 28407005
[TBL] [Abstract][Full Text] [Related]
36. Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.
Murakami T; Yi S; Maeda S; Tashiro F; Yamamura K; Takahashi K; Shimada K; Araki S
Am J Pathol; 1992 Aug; 141(2):451-6. PubMed ID: 1497094
[TBL] [Abstract][Full Text] [Related]
37. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
[TBL] [Abstract][Full Text] [Related]
38. Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.
Zemany L; Bhanot S; Peroni OD; Murray SF; Moraes-Vieira PM; Castoldi A; Manchem P; Guo S; Monia BP; Kahn BB
Diabetes; 2015 May; 64(5):1603-14. PubMed ID: 25524914
[TBL] [Abstract][Full Text] [Related]
39. Dapagliflozin treatment and cardiovascular outcome in RBP4/TTR
Li Z; Lv F; Wen X; Guo C; Li L; Cai X; Lin C; Zhang M; Yang W; Ji L
ESC Heart Fail; 2024 Feb; 11(1):179-188. PubMed ID: 37877450
[TBL] [Abstract][Full Text] [Related]
40. Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Connelly S; Mortenson DE; Choi S; Wilson IA; Powers ET; Kelly JW; Johnson SM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3441-3449. PubMed ID: 28625364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
